CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Krystal Biotech, Inc. - KRYS CFD

164.51
2.42%
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon: 14:30 - 21:00

Tue: 14:30 - 18:00

Thu - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.76
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023374 %
Charges from full value of position ($-0.23)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
-0.023374%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001151 %
Charges from full value of position ($0.01)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
0.001151%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 50.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 160.63
Open 161.1
1-Year Change 35.61%
Day's Range 161.1 - 165.39
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 20, 2024 164.51 5.32 3.34% 159.19 165.73 158.95
Dec 19, 2024 160.63 4.02 2.57% 156.61 162.10 154.95
Dec 18, 2024 156.26 -20.75 -11.72% 177.01 177.01 155.17
Dec 17, 2024 168.84 3.26 1.97% 165.58 169.40 164.16
Dec 16, 2024 167.34 6.01 3.73% 161.33 172.46 161.32
Dec 13, 2024 163.70 -8.26 -4.80% 171.96 171.96 162.10
Dec 12, 2024 173.13 -16.00 -8.46% 189.13 191.64 169.95
Dec 11, 2024 186.48 2.48 1.35% 184.00 186.95 183.43
Dec 10, 2024 185.63 4.23 2.33% 181.40 187.15 181.40
Dec 9, 2024 184.24 1.85 1.01% 182.39 187.10 179.86
Dec 6, 2024 185.19 5.23 2.91% 179.96 185.73 178.88
Dec 5, 2024 179.42 -6.05 -3.26% 185.47 185.98 179.17
Dec 4, 2024 187.34 2.39 1.29% 184.95 189.95 184.95
Dec 3, 2024 185.74 -7.56 -3.91% 193.30 195.01 185.58
Dec 2, 2024 194.75 0.01 0.01% 194.74 197.92 191.11
Nov 29, 2024 197.34 1.67 0.85% 195.67 199.66 193.92
Nov 27, 2024 196.30 2.13 1.10% 194.17 198.17 193.97
Nov 26, 2024 196.22 5.12 2.68% 191.10 196.43 190.03
Nov 25, 2024 194.12 3.17 1.66% 190.95 197.21 190.82
Nov 22, 2024 190.35 11.05 6.16% 179.30 191.06 178.81

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
Leverage
2:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Krystal Biotech, Inc. Company profile

About Krystal Biotech Inc

Krystal Biotech, Inc. is a clinical stage biotechnology company focused on redosable gene delivery for the treatment of serious rare diseases. Using its platform that is based on engineered herpes simplex virus type 1 (HSV-1), the Company create vectors that deliver therapeutic transgenes to cells of interest in multiple organ systems. The Company’s gene therapy product candidates and undertaking preclinical studies and clinical trials of B-VEC, KB105, KB301, KB104, KB407 and KB408. The Company's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, and dehydration.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Krystal Biotech Inc revenues was not reported. Net loss increased from $32.2M to $69.6M. Higher net loss reflects General and Administrative - Balancing increase from $12.8M to $30.2M (expense), Stock-based Compensation in SGA increase from $2.3M to $10.2M (expense), Research and Development - Balancing increase of 44% to $24.5M (expense).

Industry: Bio Therapeutic Drugs

2100 Wharton St Ste 701
PITTSBURGH
PENNSYLVANIA 15203
US

People also watch

ETH/USD

3,297.27 Price
-0.620% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

US100

21,269.40 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

XRP/USD

2.22 Price
-0.370% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01107

Gold

2,623.59 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0151%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading